Derma Sciences (DSCI) Tops Q2 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Derma Sciences Reports Second Quarter Financial Results
August 10, 2015 7:30 AM EDTConference call begins at 11:00 a.m. Eastern time today
PRINCETON, N.J.--(BUSINESS WIRE)-- Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three and six months ended June 30, 2015.
Financial highlights of the second quarter of 2015 include (all comparisons are with the second quarter of 2014):
Advanced Wound Care (AWC) net product sales increased 16.8% to $10.3 million or 18.1% on a constant currency basis, with growth led by sales of TCC-EZ®, and AMNIOEXCEL® and... More